RE:OUCH
From Titan's latest news release: "... the company has decided to pursue a broader set of surgical indications for the Sport surgical system, including general abdominal, gynecologic and urologic procedures. Therefore, management has determined that it is appropriate to update the technology development milestones and estimated costs that were previously published. Based on "voice of customer" feedback and further consultations with the company's development partners and the newly formed surgeon advisory board, the company is building additional prototypes and developing more advanced instruments and training systems for expanded use in additional surgical procedures."
There seems to be a lot of uncertainty about TMD's expansion of Sport's capabilities, and how development costs and milestones will be affected. Until that is clarified, I suspect TMD share price will suffer a bit.